Drug General Information (ID: DDIPG7X6UV)
  Drug Name Antithymocyte immunoglobulin (rabbit) Drug Info Ustekinumab Drug Info
  Drug Type Polyclonal antibody Monoclonal antibody
  Therapeutic Class Antiinflammatory Agents Interleukin Inhibitors

 Mechanism of Antithymocyte immunoglobulin (rabbit)-Ustekinumab Interaction (Severity Level: Moderate)
     Additive immunosuppressive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Antithymocyte immunoglobulin (rabbit) Ustekinumab
      Mechanism 1 Immunosuppressive effects Immunosuppressive effects
      Key Mechanism Factor 1
Factor Name Immunosuppressive effects
Factor Description Immunosuppression is when your immune system is not functioning as it should. The immune system is made up of cells, tissues and organs that help the body fight off infections. If the immune system is suppressed, an infection that your body was able to control may become serious or even fatal.
      Mechanism Description
  • Additive immunosuppressive effects by the combination of Antithymocyte immunoglobulin (rabbit) and Ustekinumab 
      Mechanism 2 Myelosuppressive effects Myelosuppressive effects
      Key Mechanism Factor 2
Factor Name Immunosuppressive effects
Factor Description Immunosuppression is when your immune system is not functioning as it should. The immune system is made up of cells, tissues and organs that help the body fight off infections. If the immune system is suppressed, an infection that your body was able to control may become serious or even fatal.
      Mechanism Description
  • Additive immunosuppressive effects by the combination of Antithymocyte immunoglobulin (rabbit) and Ustekinumab 

Recommended Action
      Management Caution is advised if ustekinumab must be used in patients who have recently received or are receiving treatment with other immunosuppressive or myelosuppressive drugs, and vice versa. Close clinical and laboratory monitoring for the development of severe hematologic adverse effects is recommended both during and after discontinuation of therapy.

References
1 Product Information. Stelara (ustekinumab). Centocor Inc, Malvern, PA.